OpenAlex
PricingAboutJobs
Log inGet started
Work

Growth Differentiation Factor 15, a Marker of Oxidative Stress and Inflammation, for Risk Assessment in Patients With Atrial Fibrillation: Insights From the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) Trial

HTML

Year: 2014
Type: article
Source: Circulation
DOI: 10.1161/circulationaha.114.011204
Authors: Lars Wallentin, Ziad Hijazi, Ulrika Andersson, John H. Alexander, Raffaele De Caterina, Michael Hanna, John D. Horowitz, Elaine M. Hylek, Renato D. Lopes, Signild Åsberg, Christopher B. Granger, Agneta Siegbahn
Institutions: Boston University, Uppsala University, Boston Medical Center, University of Chieti-Pescara, Bristol-Myers Squibb (United States), Duke Medical Center, Fondazione Toscana Gabriele Monasterio, The University of Adelaide
Language: English

Topic: GDF15 and Related Biomarkers
Subfield: Cardiology and Cardiovascular Medicine
Field: Medicine
Domain: Health Sciences
Keywords: growth differentiation factor 15, atrial fibrillation, prognostic factors, apixaban, warfarin, stroke and systemic embolism, major bleeding, mortality, high-sensitivity troponin I, N-terminal pro-brain natriuretic peptide, oxidative stress, inflammation, ARISTOTLE trial, risk stratification, anticoagulation, cardiovascular risk
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W2145179900
FWCI: 16.05
Cites: 40
Cited by: 336
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms